Advertisement

Topics

Orthofix International Reports Fourth Quarter and Fiscal 2016 Financial Results

16:03 EST 27 Feb 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Fourth Quarter Highlights Net sales of $108.5 million, an increase of 3.7% compared to prior year and 4.2% on a constant currency basis Net loss from continuing operations of $5.1 million; comp...

Other Sources for this Article

Orthofix International N.V.
Mark Quick, 214-937-2924
markquick@orthofix.com

NEXT ARTICLE

More From BioPortfolio on "Orthofix International Reports Fourth Quarter and Fiscal 2016 Financial Results"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...